However, the consistently reported absence of an inflammatory tumor micro-environment (TME) in these subpopulations predisposes them to few non-synonymous mutations and explain the limited efficacy of PD-1/PD-L1 inhibitors [34]. The gene discussed is CD274; the disease is neoplasm.